It was shown that SNCG interacts with AR and promotes prostate cancer cellular growth and proliferation by activating AR transcription in an androgen-dependent manner, whereas SNCG was almost undetectable in benign or androgen-independent tissues prostate lesions. The gene discussed is AR; the disease is prostate carcinoma.